Dengue dynamics and vaccine cost-effectiveness in Brazil.
Ontology highlight
ABSTRACT: Recent Phase 2b dengue vaccine trials have demonstrated the safety of the vaccine and estimated the vaccine efficacy with further trials underway. In anticipation of vaccine roll-out, cost-effectiveness analysis of potential vaccination policies that quantify the dynamics of disease transmission are fundamental to the optimal allocation of available doses. We developed a dengue transmission and vaccination model and calculated, for a range of vaccination costs and willingness-to-pay thresholds, the level of vaccination coverage necessary to sustain herd-immunity, the price at which vaccination is cost-effective and is cost-saving, and the sensitivity of our results to parameter uncertainty. We compared two vaccine efficacy scenarios, one a more optimistic scenario and another based on the
SUBMITTER: Durham DP
PROVIDER: S-EPMC3755607 | biostudies-literature | 2013 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA